Epstein-Barr virus (EBV) is an oncogenic c-herpes virus associated with malignancies that develop in both lymphoid and epithelial cells including nasopharyngeal carcinoma (NPC). The EBV protein, latent membrane protein 2A (LMP2A), is expressed in NPC and can modulate epithelial proliferation, transformation and differentiation, and as such may promote malignancy. A key regulator of epithelial-cell differentiation is the transcription factor p63, a member of the p53 family. This study examines the potential contribution of p63 to LMP2A-mediated inhibition of epithelial-cell differentiation. Stable expression of LMP2A increased the protein level and stability of the DNp63a isoform and in two epithelial cell lines, LMP2A interacted with DNp63a under stable-and transient-expression systems. LMP2A and DNp63a were localized to the cytoplasm and nuclear membrane and co-immunoprecipitated in the same fractions. Following induction of epithelial-cell differentiation by calcium, expression of differentiation markers was impaired in both DNp63a-and LMP2A-expressing cells. Induction of p63a, association of p63a with LMP2A and impairment of differentiation required the PY and immunoreceptor tyrosine-based activation motif (ITAM) signaling motif of LMP2A. By associating with and being regulated by LMP2A, DNp63a may function as a unique regulator of LMP2A effects on epithelial differentiation and contribute to EBV-associated epithelial cancers.
Introduction
Epstein-Barr virus (EBV) is an oncogenic g-herpes virus associated with several malignancies including Burkitt's lymphoma, Hodgkin's lymphoma and nasopharyngeal carcinoma (NPC; Brooks et al., 1992; Busson et al., 1992; Young and Rowe, 1992; Raab-Traub, 1992a , 1992b , 2002 . Most individuals are infected early in life and develop life-long latency, with some primary infections inducing infectious mononucleosis. Although primarily B-cell tropic, EBV infects other cell types, such as epithelial cells, and is considered a major factor in the development of NPC (Brooks et al., 1992; Busson et al., 1992; Raab-Traub, 1992a , 1992b . There are at least three different gene-expression patterns in latently infected cells, latency I, II and III. Many of the EBVassociated cancers, including NPC and Hodgkin's lymphoma, have the EBV latency pattern II characterized by expression of the nuclear protein EBNA-1 and the membrane proteins, latent membrane protein 1 and 2 (LMP1 and LMP2; Brooks et al., 1992; Busson et al., 1992; Raab-Traub, 1992a , 1992b . LMP2A mimics Bcell receptor signaling to promote cell survival and proliferation of B-cells (Merchant et al., 2001) . In epithelial cells, LMP2A can induce transformation, promote motility, and inhibit differentiation, all functions that can promote malignant cell growth (Scholle et al., 2000; Fukuda and Longnecker, 2007; Bultema et al., 2009) . One of the key regulators of epithelial cell development and differentiation is the transcription factor p63.
p63 is member of the p53 family of transcription factors and is preferentially expressed in epithelial cells (Murray-Zmijewski et al., 2006; Candi et al., 2007 Candi et al., , 2008 Truong and Khavari, 2007; Medawar et al., 2008; Ogawa et al., 2008) . p63 exists as six distinct isoforms generated by two different promoters, TAp63 and DNp63, and C-terminal alternative splicing to produce TAp63a, DNp63a, TAp63b, DNp63b, TAp63g and DNp63g. The TAp63 isoforms contain an N-terminal transactivating domain missing in DNp63a, consequently TAp63 has traditionally been considered an activating transcription factor (Murray-Zmijewski et al., 2006; Candi et al., 2007 Candi et al., , 2008 Truong and Khavari, 2007; Medawar et al., 2008; Ogawa et al., 2008) . The isoforms can be distinguished by their molecular weights such that all the TA isoforms are approximately 10 kDa larger than the corresponding DN isoforms. Recently, DNp63a has been shown to be the main p63 isoform expressed in keratinocytes and also to be essential for epithelial development and differentiation (Koster et al., 2004; Candi et al., 2008) . DNp63a is highly expressed in basal, proliferating keratinocytes and is associated with inhibition of terminal differentiation-marker expression as cells progress through the differentiation pathway (Bamberger et al., 2002; Candi et al., 2008; Ogawa et al., 2008) . In addition, DNp63 expression has been detected in human malignancies including NPC and may participate in disease pathogenesis by promoting cell proliferation and inhibiting differentiation (Guo et al., 2006; Candi et al., 2007; Okuyama et al., 2007; Truong and Khavari, 2007; Yip and Tsao, 2008) .
To evaluate the potential role of p63 in LMP2A-mediated inhibition of differentiation, p63 expression was determined in epithelial cells expressing LMP2A and in cells induced to differentiate. The data indicate that LMP2A increased the expression levels and stability of DNp63a, and is physically associated with DNp63a at the nuclear membrane. Both p63 and LMP2A impaired the expression of the differentiation markers involucrin, keratin 1 and keratin 10. The effects on p63 and inhibition of differentiation by LMP2A required the PY and immunoreceptor tyrosine-based activation motif (ITAM) signaling motifs.
Results

LMP2A induces expression and stability of p63a in epithelial cells
Several signaling motifs have been identified in LMP2A including a potential src kinase-binding site (YEEA), an ITAM that binds the Syk tyrosine kinase and two PY motifs that bind WW domain-containing ubiquitin ligases. LMP2A has previously been shown to inhibit differentiation in epithelial cells and the PY motif is required for the inhibition of involucrin expression upon differentiation in human foreskin keratinocytes (Scholle et al., 2000; Morrison and Raab-Traub, 2005) . The ubiquitin ligase Itch interacts with the LMP2A PY motifs and regulates degradation of LMP2A and LMP2A-associated signaling mediators (Ikeda et al., , 2003 Longnecker et al., 2000; Rossi et al., 2006a Rossi et al., , 2006b . One target of Itch is p63, a transcription factor belonging to the p53 family, that has been identified as a key regulator of epithelial-cell growth and differentiation (Murray-Zmijewski et al., 2006; Candi et al., 2007 Candi et al., , 2008 Truong and Khavari, 2007; Medawar et al., 2008; Ogawa et al., 2008) . DNp63a is associated with impaired epithelial cell differentation and with NPC, and as such may provide a key target for LMP2A signaling. To determine whether LMP2A affects DNp63a, its expression and stability were studied in HaCaT cells stablyexpressing LMP2A.
Using antibody specific for total p63a, immunoblotting of whole cell lysates revealed that LMP2A increased the protein levels of an approximately 72 kDa protein, compared with pBabe, consistent with the size of DNp63a (Figure 1a ). Antibody specific for DNp63 indicated that the 72 kDa protein was DNp63a and quantitation relative to actin indicated that LMP2A increased the levels by approximately 50% (Figures 1a  and b) . The LMP2A-induced increase in DNp63a expression was impaired by mutation of the LMP2A PY motifs or by deletion of the ITAM motif (Figures 1a   and b) . In contrast, the YEAA motif did not impair the increased DNp63a expression. The ITAM mutant that also lacks one PY domain was consistently expressed at higher levels perhaps reflecting its impaired activity and interaction with ubiquitin ligases. These findings suggest that the LMP2A-induced increase in DNp63a levels required PY and ITAM. Quantitative real-time PCR, which distinguished the two distinct amino-terminal forms, revealed that the DNp63 isoform was predominant in HaCaT cells with essentially no expression of TAp63 (Figure 1c ) further implicating DNp63a as the isoform targeted by LMP2A. Importantly, LMP2A did not increase the relative transcription of either form (data not shown) suggesting that DNp63a regulation by LMP2A was post-transcriptional.
To determine the effect of LMP2A on p63a protein stability, HaCaT cells expressing pBabe or LMP2A were treated with cycloheximide to inhibit protein synthesis, and p63a expression was determined by western blot. pBabe cells had a time-dependent decrease in p63a expression whereas in LMP2A cells, p63a expression did not decrease in the presence of a protein synthesis inhibitor, suggesting that LMP2A increased the expression p63a through effects on its stability (Figures 1d  and e) . A half-life for p63a in LMP2A cells could not be calculated because a slight increase in p63a expression relative to actin from time 0 to 24 h gave a line of best fit with a positive slope, indicating no degradation of p63a (Figure 1e ). LMP2A expression decreased in a timedependent manner following cycloheximide treatment indicating that LMP2A did not impair the protein degradation machinery in HaCaT cells (Figure 1d ). The increased stability of DNp63a has also been described in NPC cell lines (Guo et al., 2006) .
To determine if LMP2A-induced p63a protein stability was caused by impaired proteasome-mediated degradation, pBabe-and LMP2A-expressing cells were treated with the proteasome inhibitor MG132. In pBabe cells, treatment using MG132 increased the p63a expression to levels equivalent to those in LMP2A-expressing cells compared with treatment using the dimethyl sulfoxide vehicle control, indicating that p63a is regulated by proteasome-mediated degradation (Figure 1f ). In contrast, p63a levels in LMP2A cells were unchanged when treated with MG132 compared with dimethyl sulfoxide and were similar to p63a levels in pBabe cells treated with MG132 (Figure 1f ). These findings suggest that LMP2A impairs proteasomemediated degradation of p63a in pBabe cells (Figure 1f ). The Itch ubiquitin ligase, which is known to regulate p63, was increased by LMP2A and inhibition of the proteasome did not affect Itch levels (Figure 1f ).
LMP2A and p63a interact in cytoplasmic and nuclear membrane fractions in epithelial cells To assess the effects of LMP2A on the subcellular localization of Itch and p63a, HaCaT cells stably expressing LMP2A, LMP2A mutants, and DNp63a were fractionated into cytoplasm, nucleoplasm and nuclear membrane. Protein expression was determined by western blot (Figure 2a ) and the levels of the specific proteins in each fraction are presented as % of the total individual protein with s.e. calculated from three or more experiments (Figures 2b-d) . The purity of the fractions was determined using the endoplasmic reticulum marker GRP78 and the nuclear membrane marker emerin (data not shown). In the pBabe vector control cells, Itch was predominantly detected in the cytoplasm and nucleoplasm fractions with a low expression detected in the nuclear membrane (Figures 2a and b) . Stable expression of LMP2A, PY, YEEA or DNp63a did not affect Itch localization or levels; however, loss of the ITAM motif decreased the cytoplasmic expression and increased the nuclear expression of Itch (Figures 2a and b) .
In the vector control cells, p63a localized primarily to the cytoplasm and nuclear membrane fractions ( Figures  2a and c) . Stable expression of LMP2A, PY, ITAM, YEEA or DNp63a did not significantly affect p63 localization (Figures 2a and c) . However, the low levels of expression of p63a in pBabe, ITAM and DNp63a cells compared with LMP2A-induced expression, required longer exposures to detect bands for quantitation (Figures 2a and c) . The lower overall expression of p63a in pBabe and ITAM cells was consistent with the lower expression detected in whole cell lysates ( Figure 1a ). Full-length LMP2A and all LMP2A mutants were predominately cytoplasmic with some expression in the nuclear-membrane fraction (Figures 2a and d) .
To determine the potential interaction of LMP2A and p63a, LMP2A was immunoprecipitated using cytoplasm from the pBabe control cells and from the cytoplasm, nucleoplasm and nuclear membranes from LMP2A-expressing HaCaT cells. Itch and p63a were detected with LMP2A precipitated from the cytoplasm and the nuclear membrane ( Figure 2e ). Neither Itch nor p63a was detected in the immunoprecipitated material from the pBabe lysates with the LMP2A antibody or by using beads alone in the absence of antibody, indicating that their precipitation required LMP2A and did not reflect a non-specific interaction of Itch or p63a with the LMP2A antibody. These findings indicate that LMP2A interacts with endogenous p63 and confirms the interaction of LMP2A and Itch that has been previously described (Ikeda et al., , 2003 Longnecker et al., 2000) .
The ability of LMP2A to interact with the DNp63a isoform was evaluated in HEK293 cells that do not endogenously express detectable levels of p63a (data not shown), transfected with an expression construct for DNp63a. Endogenous Itch was detected in the cytoplasm, nucleoplasm and nuclear membrane of the vector control HEK293 cells (Figures 3a and b) . Transiently expressed LMP2A was predominantly detected in the nuclear membrane compared with the stably expressing LMP2A HaCaT cells. Localization of transiently expressed DNp63a was also primarily in the nuclear membrane with equivalent levels detected in the cytoplasm and nucleoplasm (Figures 3a and c) . The different localization of DNp63a and LMP2A in transient-and stable-expression systems suggests that initial protein expression is detected in the nuclear membrane, whereas stably expressed or endogenous proteins associate with cytoplasmic components. Surprisingly, the relative levels of nuclear DNp63a decreased in the presence of LMP2A. The interaction of DNp63a with Itch and LMP2A was evaluated in the cytoplasm, nucleoplasm and nuclear membrane fractions of the transiently transfected HEK293 cells. Itch interacted with DNp63a in the nuclear membrane where DNp63a was predominantly expressed (Figure 3e) . Similarly, LMP2A also interacted with DNp63a at the nuclear membrane. While protein localization differed in transient-and stable-expression systems, LMP2A and DNp63a interacted under both conditions.
To determine which signaling motifs were required for the interaction of LMP2A with p63a, LMP2A was immunoprecipitated from HEK293 cells transiently expressing full-length or mutated LMP2A. DNp63a was detected at equivalent levels with immunoprecipitated LMP2A or LMP2A with the mutated YEEA motif, but was significantly decreased with the PY and ITAM mutations (Figure 3f) . Similarly, the interaction of Itch with LMP2A also required the PY and ITAM motifs (Figure 3f ). The decreased immunoprecipitation of both DNp63a and Itch with these LMP2A mutants confirmed that Itch and DNp63a do not nonspecifically precipitate with the LMP2A antisera. The low level of Itch detected with LMP2A likely reflects that only a subset of the total Itch is present in the nuclear membrane where LMP2A is predominantly detected. The requirement of PY and ITAM for both interactions suggests that p63a, Itch and LMP2A may exist as a complex.
LMP2A co-localizes with p63a
The potential interaction of LMP2A and p63a was also evaluated in HEK293 cells transiently expressing LMP2A and DNp63a, and in HaCaT cells stably expressing LMP2A, using immunofluorescent staining to identify colocalization. In HEK293 cells (Figure 4 , panels ii through iv), LMP2A and p63a colocalized with 
Localization of LMP2A-Itch-p63a complexes in HaCaT cells was determined by immunoprecipitation of LMP2A in fractionated lysates followed by western blot for p63a and Itch. LMP2A was immunoprecipitated from pBabe (pB) cytoplasmic, and from LMP2A C, N and NM fractions. For beads-only controls (B), protein G beads were added to pBabe and LMP2A cytoplasmic fractions, without an antibody IP, to assess non-specific protein binding. pB, pBabe; L2A, LMP2A; p63, p63a. striking perinuclear staining confirming the cell fractionation and co-immunoprecipitation analyses (Figure 3) . Similarly, LMP2A and endogenous p63a primarily had perinuclear co-localization in HaCaT cells, suggesting that they interact at the nuclear membrane with some interaction evident in the cytoplasm (Figure 4 panels vi-viii). The less intense staining of both LMP2A and p63 in HaCaT cells is likely a consequence of more uniform, stable and less abundant expression of these proteins, whereas both proteins were transiently expressed in HEK293 cells and were stained 48 h following transfection. Background staining with fluorescein isothiocyanate anti-rat or cyanine 3 anti-mouse antibodies was not detected in either HEK293 cells or HaCaT cells (Figure 4 panels ix-xii).
LMP2A impairs epithelial cell differentiation induced by calcium
To determine the effects of LMP2A and DNp63a on epithelial cell differentiation, HaCaT cells were grown for 3 weeks in calcium-free dulbecco's modified eagle medium to decrease differentiation. In the original calcium-containing growth media, HaCaT cells expressed high levels of the early differentiation marker keratin 10 and the intermediate differentiation marker involucrin (Figure 5a , day -5). Following treatment for 3 weeks without calcium, HaCaT cells with or without LMP2A acquired an undifferentiated morphology (data not shown; Deyrieux and Wilson, 2007) with reduced levels of keratin 10 and involucrin (Figure 5a ). The levels of keratin 10 and involucrin relative to glyceraldehyde 3-phosphate dehydrogenase confirmed this decrease and indicated that LMP2A did not significantly affect the expression of these markers in de-differentiated cells (Figure 5b) .
It is known that differentiation can be induced in proliferating keratinocytes by exposure to calcium. The effects on expression of keratin 10 and involucrin mRNA in response to the addition of 2.8 mM CaCl 2 to the growth media of the de-differentiated HaCaT cells were determined. HaCaT pBabe cells had a slight time-dependent increase in calcium-induced mRNA expression of the early differentiation marker keratin 1 (Figure 5c ) and a clear induction of mRNA for Localization of LMP2A-p63a-Itch complexes was determined by immunoprecipitation of p63a from fractionated lysates (cytoplasmic-C, nuclear-N, nuclear membrane fractions-NM) followed by western blot for LMP2A and Itch. For beads-only controls, protein G beads were added to DNp63a and DNp63a þ LMP2A cytoplasmic fractions, without an antibody IP, to determine non-specific protein binding. (f) Requirement of LMP2A signaling motifs for association of LMP2A with p63a was determined by immunoprecipitation of LMP2A from HEK293 cells transiently expressing pBabe, LMP2A or the PY, ITAM or YEEA mutants of LMP2A, followed by western blot for Itch and p63a. For beads-only controls, protein G beads were added to LMP2A lysates, without an antibody IP, to determine non-specific protein binding. L2A, LMP2A; vect, vector.
the intermediate differentiation marker involucrin (Figure 5d ). Whereas expression of the early marker keratin 1 peaked at 48 h, expression of the intermediate marker involucrin continued to increase for 96 h in pBabe cells. In contrast, the mRNA for keratin 1 and involucrin in HaCaT LMP2A cells decreased in response to calcium and remained low over the duration of the experiment (Figures 5c and d) . Interestingly, LMP2A-expressing cells had higher mRNA levels for both markers at time zero, in particular for the early marker keratin 1, although the difference in involucrin was not at the protein level (Figure 5a , day 21). Involucrin protein expression increased in response to calcium over time in the pBabe control cells, however this induction of involucrin was impaired in cells stably expressing LMP2A confirming the decreased expression of involucrin mRNA (Figure 5e ). The impaired induction of the differentiation markers keratin 1 and involucrin in the presence of LMP2A confirms that LMP2A inhibits differentiation (Figure 5e ). Similarly, involucrin was not induced in HaCaT cells that stably expressed DNp63a indicating that DNp63a expression can mimic the effect of LMP2A on calcium-induced differentiation. Calcium-induced involucrin expression in the PY mutant was similar to that observed in pBabe cells confirming that the PY motif is required for the inhibition of differentiation by LMP2A (Figure 5e ) (Morrison and Raab-Traub, 2005 ).
To determine whether LMP2A-induced DNp63a was associated with the state of differentiation of epithelial cells, p63a protein expression was determined by western blot in HaCaT cells and normalized to actin before de-differentiation and after de-differentiation (Figure 5f ). The p63a protein levels were slightly lower in LMP2A compared with pBabe cells before dedifferentiation (Figure 5f ), suggesting that LMP2A does not induce p63a or promote a de-differentiated phenotype when it is expressed in differentiated cells. However, LMP2A clearly induced DNp63a in the dedifferentiated cells and both LMP2A and DNp63a inhibited the expression of differentiation markers after exposure to calcium. The ability of LMP2A to induce expression of DNp63a was impaired with mutation of the PY or ITAM signaling motifs (Figure 5f ). This data supports that LMP2A-induced p63a is a mediator for inhibiting keratinocyte progress through the calciuminduced differentiation pathway.
Discussion
The findings in this study reveal that in epithelial cells, expression of EBV LMP2A increased the protein levels and stability of p63a, and is physically associated with p63a in the cytoplasm and in the nuclear membrane. Both LMP2A and DNp63a impaired cellular differentiation induced by calcium, and the effects of LMP2A on p63a and intermediate differentiationmarker expression required the PY motifs. These results confirm previous findings that LMP2A-induced inhibition of involucrin in epithelial cells was dependent on its PY motif (Scholle et al., 2000; Morrison and Raab-Traub, 2005) . This is the first study to identify effects of LMP2A on p63a and the requirement for specific LMP2A signaling motifs in regulating DNp63a. It is known that p63a protein levels can be regulated through ubiquitination mediated by the ubiquitin ligase Itch that physically associates with p63a (Melino et al., 2006) . Itch also associates with other target proteins, including LMP2A, through interaction of the Itch WW domain with the target protein PY domain (Ikeda et al., , 2003 Longnecker et al., 2000; Winberg et al., 2000) . The data presented here suggest that LMP2A can modulate the effects of Itch on DNp63a resulting in increased protein levels. LMP2A co-immunoprecipitated with Itch and this complex was detected only in the cytoplasm and nuclear membrane. Similarly, LMP2A co-immunoprecipitated with DNp63a in the cytoplasm and nuclear membrane, suggesting the possibility that LMP2A, DNp63a and Itch form a complex.
The interaction of LMP2A with p63a required both the PY and the ITAM signaling domains of LMP2A as both mutants reduced complex formation. As expected, Itch was unable to interact with LMP2A in the presence of the PY mutation. The ITAM was also required for the interaction of Itch and LMP2A, although this may reflect that the ITAM deletion mutant is also missing a PY domain. It is unknown whether p63a directly binds to the PY or ITAM motifs of LMP2A. p63a contains PY domains that can bind Itch and a sterile a motif that could interact with the SH2 domains of Syk, leading to the possibility that p63a interacts with LMP2A via Itch and/or Syk as signaling mediators or as scaffold proteins. A recent study revealed that after induction of DNA damage, the stability of DNp63 was decreased due to its interaction with RACK1 and that the RACK1 effects were blocked by the interaction of DNp63 with Stxbp4 (Li et al., 2009 ). LMP2A may affect the Cells were collected and lysed at 0, 5, 24, 48, 72 and 96 h after addition of CaCl 2 . mRNA expression of keratin 1 (c) and involucrin (d) was determined by quantitative real-time PCR, was normalized to glyceraldehyde 3-phosphate dehydrogenase and is expressed relative to time 0. s.e. were calculated from three experiments each run in triplicates. (e) Protein expression of involucrin in HaCaT cells stably expressing pBabe, LMP2A, PY and DNp63a induced to differentiate with 2.8 mM CaCl 2 for 0-120 h was determined by western blot, normalized to actin and expressed graphically relative to time 0. For each time point, involucrin levels were also normalized to involucrin from HaCaT cells allowed to proliferate without calcium, to determine specific calcium-induced involucrin expression. (f) To determine if LMP2A-induced p63a was associated with epithelial-cell differentiation, p63a expression was determined by western blot from HaCaT cells before (differentiated) and after (de-differentiated) de-differentiation in Ca 2 þ free media. p63a levels were normalized to actin and are expressed graphically. L2A, LMP2A; pB, pBabe. expression of additional proteins that regulate p63 stability such as Stxbp4 or RACK1.
Both LMP2A and DNp63a inhibited expression of the intermediate epithelial differentiation marker involucrin suggesting that DNp63 may, in part, mediate the effect of LMP2A on differentiation. LMP2A is expressed in the epithelial cancer NPC (Busson et al., 1992) and by promoting transformation, motility and inhibiting differentiation, LMP2A has been implicated in promoting epithelial malignancy (Scholle et al., 2000; Fukuda and Longnecker, 2007) . DNp63a is expressed at high levels in NPC suggesting that its stabilization by LMP2A may be a contributing factor to the undifferentiated state of NPC. DNp63a has also been shown to affect the transcription of several target genes including those encoding cell-cycle proteins (Wu et al., 2003; Testoni and Mantovani, 2006; Candi et al., 2007) . It is presently unknown whether DNp63a is active as a transcription factor in the presence of LMP2A. DNp63a was barely detected in the nucleoplasm in fractionated cells but nuclear DNp63a was detectable by immunostaining. However, in an initial microarray analysis several previously identified transcriptional targets of DNp63a were upregulated in LMP2A-expressing cells including matrilin-2, Dlx3 and IL-8 (data not shown). This may indicate that DNp63a is transcriptionally active in the presence of LMP2A and could potentially regulate expression of genes involved in the regulation of differentiation. It is known that DNp63a inhibits p21 expression, a gene that is required for keratinocyte terminal differentiation (Westfall et al., 2003; Candi et al., 2007) .
It is intriguing that LMP2A regulates a protein so integral to epithelial function and differentiation. Although DNp63a inhibits expression of terminal differentiation markers such as involucrin, it is also essential for the initiation of differentiation and for the expression of early differentiation markers such as keratin 1 (Ogawa et al., 2008) . This recent finding may explain why LMP2A cells had approximately fourfold higher mRNA levels of keratin 1 compared with pBabe vector control cells. In addition, pBabe and LMP2A cells had similar morphological changes in response to calcium (data not shown), suggesting that the initiation of the differentiation program was not impaired by LMP2A. These findings are consistent with the effects of LMP2A on DNp63a contributing to the effects of LMP2A on epithelial differentiation.
Both LMP2A and DNp63a have been suggested to have oncogenic potential and are associated with epithelial cell malignancies. The effects of LMP2A on DNp63a expression and stability may be an important contributing factor to the development of EBV-associated epithelial malignancies including NPC.
Materials and methods
Differentiation of HaCaT Cells
The human keratinocyte HaCaT cell line was maintained in calcium-free dulbecco's modified eagle medium supplemented with 10% heat-inactivated fetal bovine serum, from which calcium was removed, and 1% antibiotic/antimycotic. To remove calcium, Chelex 100 resin (BioRad Laboratories, Hercules, CA, USA) was incubated with fetal bovine serum on a shaker at 4 1C for 1 h (2.5 g/50 ml) and was removed by two sequential vacuum filtrations with a 0.22 mm filter. To induce differentiation, HaCaT cells were supplemented with 2.8 mM CaCl 2 for 0-120 h. This protocol was adapted from a study investigating HaCaT cells as an in vitro model of epithelial-cell differentiation (Deyrieux and Wilson, 2007) .
Plasmids and LMP2A-expressing cell lines Stable HaCaT cell lines expressing the pBabe vector or the pBabe vector subcloned with HA-tagged LMP2A, LMP2A D PY, LMP2A D ITAM, LMP2A D YEEA or with DNp63a were generated by transduction with recombinant retroviruses expressing each vector and selection with 0.5 mg/ml puromycin as described previously (Scholle et al., 2000; Morrison and Raab-Traub, 2005) . The N-terminus of LMP2A contains two PY motifs (amino acids (aa) 56-60 and aa96-100), one ITAM motif (aa74-88) and one YEEA motif (aa112-115). The LMP2A D PY mutant contains four proline-alanine mutations at aa57, aa58, aa98 and aa99 to disrupt both PY motifs. The LMP2A D ITAM mutant contains a tyrosine-phenylalanine mutation at aa74, a deletion from aa75-111 and is consequently missing both the ITAM motif and the second PY motif. The LMP2A D YEEA mutant contains a tyrosinephenylalanine mutation at aa112. The LMP2A mutants were a generous gift from Dr R Longnecker.
To stably express DNp63a in HaCaT cells, DNp63a was subcloned into pBabe from pcDNA3-DNp63a graciously provided by Dr M Oren. HaCaT cells stably over-expressing pBabe-DNp63a were generated by retroviral transduction and selection with puromycin (0.5 mg/ml).
HEK293 cells were maintained in dulbecco's modified eagle medium containing 10% fetal bovine serum and 1% antibiotic/antimycotic and were transiently transfected for 48 h using FuGENE (Roche Applied Science, Indianapolis, IN, USA), with the pBabe and pcDNA3 vectors alone, pBabe-LMP2A, pcDNA3-DNp63a (a generous gift from Dr M Oren) and pBabe-LMP2A þ pcDNA3-DNp63a, according to manufacturer's protocol.
Western blot and immunoprecipitation
Whole-cell lysates were generated by lysis of cell pellets with radioimmunoprecipitation assay buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1 mM EDTA) and were subjected to western blot. For wholecell lysate immunoprecipitation, cell pellets were lysed with NETN buffer (0.5% NP-40, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 120 mM NaCl) and were incubated at 4 1C overnight with 2-10 mg primary antibody (LMP2 or p63a). 50 ml protein G bead slurry (GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA) was added for 1 h, beads were washed five times and bound proteins were eluted with sample buffer heated at 95 1C for 10 min.
Radioimmunoprecipitation assay/NETN buffer whole-cell lysates and IP lysates were subjected to SDS-PAGE, transferred to nitrocellulose membranes, blocked for 1 h in 5% milk/tris buffered saline-Tween and incubated overnight with primary antibody diluted in 5% milk/tris buffered salineTween (mouse anti-Itch 1:250, BD Biosciences, San Jose, CA, USA; mouse anti-involucrin 1:1000, Sigma-Aldrich, St Louis, MO, USA; anti-GRP78 1:200, Santa Cruz, Santa Cruz, CA, USA; rabbit anti-glyceraldehyde 3-phosphate dehydrogenase 1:500, Santa Cruz; goat anti-actin 1:500, Santa Cruz; rabbit anti-DNp63 1:250, BioLegend, San Diego, CA, USA; mouse anti-p63a 1:200, Santa Cruz; rat anti-LMP2 clone 14B7 1:2000, Abcam Inc., Cambridge, MA, USA; mouse antikeratin 10 1:100, NeoMarkers, Fremont, CA, USA). Membranes were washed and incubated for 1 h with horseradish peroxidase conjugated secondary antibodies (Amersham Biosciences, Piscataway, NJ, USA and Dako, Carpinteria, CA, USA) diluted 1:1000 in 5% milk/tris buffered saline-Tween. Western blots were washed and developed with Pierce Supersignal West Pico System (Thermo Fisher Scientific, Rockford, IL, USA). Band volumes were measured with ImageJ64 software (National Institutes of Health, Bethesda, MD, USA).
Cell fractionations
Cell pellets were isolated and resuspended in 200-300 ml of hypotonic lysis buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.6)/10 mM NaCl/1.5 mM MgCl 2 / 0.1% Nonidet P-40/10% glycerol, 0.5 mM dichlorodiphenyltrichloroethane/0.4 mM phenylmethylsulfonyl fluoride/1 mM NaF/0.1 mM NaVO 4 /Complete Mini protease inhibitors (Roche, Indianapolis, IN, USA)). Lysates were incubated on ice for 15 min and centrifuged for 5 min at 1000 g (4 1C). Supernatants were reserved and cell pellets were washed once with 100 ml of hypotonic lysis buffer and centrifuged for 5 min at 1000 g (4 1C). Supernatants were combined with the previous supernatant to yield the cytoplasmic fraction.
The nuclear pellets were manually homogenized using a dounce homogenizer with 1 mM EDTA containing protease inhibitors. Nuclear lysates were centrifuged at 300 g for 10 min at 4 1C. The clear supernatant was collected and centrifuged at 20 000 g for 20 min at 4 1C to separate the particulate fraction. Supernatants were collected and reserved (nucleoplasm) and pellets were resuspended in homogenization buffer (nuclear membranes).
Real-time PCR RNA lysis buffer was added to freshly isolated cell pellets and lysates were stored at À80 1C until extraction. Total RNA was purified using the Qiagen RNeasy Plus kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. mRNA expression levels of involucrin, keratin 1, TAp63, DNp63 and actin were determined using the Qiagen QuantiTech SYBR-green real-time PCR kit (Qiagen) according to the manufacturer's instructions and SYBR-green labeled PCR products were detected using an Applied Biosystems 7900HT real-time PCR system, Bedford, MA, USA.
Immunofluorescence Cells were plated into 8-well permanox-coated chamber slides and were allowed to attach overnight. Slides were gently washed with phosphate-buffered saline and fixed for 15 min with ice-cold acetone:methanol (1:1) and blocked for 15 min at room temperature with 3% bovine serum albumin in phosphate-buffered saline. Primary antibodies were prepared in phosphate-buffered saline (rat anti-LMP2 clone 4E11 1:2000 (Abcam, Cambridge, MA, USA), mouse anti-p63a (Santa Cruz Biotechnology, Santa Cruz, CA, USA)) and incubated for 1 h at room temperature in a humidified chamber. Slides were washed and incubated in a humidified chamber for 1 h at room temperature with secondary antibodies prepared in phosphate-buffered saline (anti-rat fluorescein isothiocyanate 1:100 (Jackson ImmunoResearch Laboratories, West Grove, PA, USA), anti-mouse cyanine 3 1:100, Jackson ImmunoResearch Laboratories). Slides were then washed and mounted with glass coverslips using anti-fade mounting media. Samples were visualized using an Olympus FV500 confocal laser scanning microscope at the Microscopy Services Laboratory at the University of North Carolina, Chapel Hill, NC, USA.
